Razor's Edge Ventures

Razor's Edge Ventures, established in 2011 and based in Reston, Virginia, is a multi-stage venture capital firm. It invests in high-growth technology companies that operate at the intersection of the national security sector and commercial enterprise markets. The firm focuses on sectors such as cybersecurity, artificial intelligence, machine learning, aerospace and defense technologies, and other advanced solutions serving both government and commercial applications. Razor's Edge Ventures typically invests between $2 million and $10 million, seeking either controlling or minority stakes, and often leads investments or joins syndicated rounds. The firm offers strategic support and access to thought leaders, leveraging its team's experience and insights into market shifts.

Jack Kerrigan

Co-Founder and Managing Partner

Richard Moxley

Co-Founder and Managing Partner

Steve Pann

Co-Founder and Managing Partner

Mary Styer

Co-Founder and Managing Partner

Past deals in Pennsylvania

Proscia

Series D in 2025
Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.

Proscia

Series C in 2024
Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.

Proscia

Series C in 2022
Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.

Proscia

Series A in 2018
Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.